Miltefosine in visceral leishmaniasis

Lancet Infectious Diseases

Volumn 3, Issue 2, 2003, Pages 70-

  Olliaro, Piero L ^a,d   Ridley, Robert G ^a   Engel, Jurgen ^b   Sindermann, Herbert ^b   Bryceson, Anthony D M ^c  

^a WORLD BANK   (United States)

^b Zentaris AG   (Germany)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MILTEFOSINE;

INFERTILITY; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; SHORT SURVEY; VISCERAL LEISHMANIASIS;

EID: 0037308124     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(03)00512-7     Document Type: Short Survey

References (1)

1. Guerin Pj, Olliaro P, Sundar S, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2: 494-501.